Skip to content
Sunday, November 8, 2026
Solid Center US

The Zimbabwean Government Declines ‘One-Sided’ American Healthcare Assistance Deal Over Information Fears

Health funding illustration
The offered US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malaria.

The nation of Zimbabwe has turned down a major American healthcare agreement worth 367 million US dollars (272 million pounds) over five years over Washington's insistence on confidential information.

The decision came to light after a internal memorandum from December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "skewed".

A government spokesman later explained that the United States was seeking biological samples for scientific study and commercial gain but was not willing to guarantee the benefits from any future medical innovations.

"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for continued negotiations to secure a deal acceptable to both sides so the country's vital HIV treatment initiative can continue.

Wider Background

Zimbabwe's decision follows a similar situation in Kenya, where a high court halted a related deal with the US after concerns were raised about the security of Kenyans' medical information.

After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government agreements to boost transparency and accountability.

Based on reports, Sixteen nations in Africa have so far signed these new health pacts, constituting more than $18.3bn of fresh investment.

Details of the Declined Deal

The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"Our nation was requested to provide its biological resources and data indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," he stated.

"Put simply, our country would supply the raw materials for scientific discovery with no certainty that the final treatments would be available to our people if a new health crisis arise."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks already established via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.

"This mechanism is designed to ensure that when a nation provides its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to develop them."

These objections regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We welcome ongoing discussions with our US partners on how future collaboration might be structured in a way that respects the independence and dignity of each country."

Medical Community Reaction

A leading public health body expressed it recognised the official position, but urged that talks need to persist since much of the country's HIV programmes relied on foreign aid.

"In cases where technical issues arise, including those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group added.

This impasse emphasises the continuing debate between accepting much-needed foreign assistance and protecting national sovereignty in an increasingly data-driven world.

About the author

Charles Scott

Maya Chen is a technology journalist and community advocate with over a decade of experience in digital media and content creation.

Solid Center US

Type to search articles.